Suppr超能文献

首次深入研究俄罗斯克拉霉素耐药幽门螺杆菌临床分离株的全基因组序列变异。

First insight into the whole genome sequence variations in clarithromycin resistant Helicobacter pylori clinical isolates in Russia.

机构信息

Laboratory of Identification of the Pathogens/Laboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, St. Petersburg, Mira Street, 197101, Russia.

Laboratory of Identification of the Pathogens, St. Petersburg Pasteur Institute, St. Petersburg, Mira Street, 14, 197101, Russia.

出版信息

Sci Rep. 2024 Aug 29;14(1):20108. doi: 10.1038/s41598-024-70977-4.

Abstract

Clarithromycin (CLR) is currently a key antibiotic for Helicobacter pylori infection treatment, however, the data on CLR resistance patterns in Russia are missing. Here, we applied WGS-based approach to H. pylori clinical isolates from Russia to comprehensively investigate sequence variation, identify putative markers of CLR resistance and correlate them with phenotypic susceptibility testing. The phenotypic susceptibility of 44 H. pylori isolates (2014-2022) to CLR was determined by disc diffusion method: 23 isolates were CLR-resistant and 21-CLR-susceptible. All isolates were subjected to WGS and submitted to GenBank. Based on complete sequence analysis, we showed that among all sequence variants, the combination of mutations A2146G/A2147G in the 23S rRNA gene is the most reliable for prediction of phenotypic susceptibility. For the first time, the average number of mutations in 106 virulence-associated genes between resistant and susceptible groups were compared. Moreover, this study presents the first WGS insight into genetic diversity of H. pylori in Russia with a particular focus on the molecular basis of drug resistance: the novel mutations were described as potential markers for the resistance development. Of these, the most prominent was a frameshift deletion (252:CGGGT) in HP0820 coding region, which is a good candidate for further investigation.

摘要

克拉霉素(CLR)目前是治疗幽门螺杆菌感染的关键抗生素,然而,俄罗斯关于 CLR 耐药模式的数据尚不清楚。在这里,我们应用基于 WGS 的方法对俄罗斯的幽门螺杆菌临床分离株进行研究,以全面调查序列变异,确定 CLR 耐药的潜在标记物,并将其与表型药敏试验相关联。采用纸片扩散法对 44 株(2014-2022 年)幽门螺杆菌分离株对 CLR 的表型药敏性进行了测定:23 株为 CLR 耐药,21 株为 CLR 敏感。所有分离株均进行 WGS 并提交至 GenBank。基于完整序列分析,我们表明在所有序列变异中,23S rRNA 基因中的突变 A2146G/A2147G 的组合是预测表型药敏性最可靠的。首次比较了耐药和敏感组中 106 个毒力相关基因中的平均突变数。此外,本研究首次对俄罗斯的幽门螺杆菌遗传多样性进行了 WGS 分析,特别关注耐药的分子基础:描述了新的突变作为耐药发展的潜在标记物。其中,最突出的是 HP0820 编码区的框移缺失(252:CGGGT),这是进一步研究的良好候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5628/11362316/5fba38780984/41598_2024_70977_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验